Araştırma Çıktıları

Permanent URI for this communityhttps://hdl.handle.net/11443/931

Browse

Author: search.filters.author.Senbaklavaci, Omer

Search Results

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    Turkish translation and transcultural adaptation of Severe Respiratory Insufficiency (SRI) questionnaire
    (TURKISH ASSOC TUBERCULOSIS \& THORAX, 2017-01-01) Ergan, Begum; Dabak, Gul; Senbaklavaci, Omer; Uslu, Selen; Windisch, Wolfram
  • No Thumbnail Available
    Item
    History of Lung Transplantation
    (BILIMSEL TIP PUBLISHING HOUSE, 2016-01-01) Dabak, Gul; Senbaklavaci, Omer
    History of lung transplantation in the world can be traced back to the early years of the 20th century when experimental vascular anastomotic techniques were developed by Carrel and Guthrie, followed by transplantation of thoracic organs on animal models by Demikhov and finally it was James Hardy who did the first lung transplantation attempt on human. But it was not until the discovery of cyclosporine and development of better surgical techniques that success could be achieved in that field by the Toronto Lung Transplant Group led by Joel Cooper. Up to the present day, over 51.000 lung transplants were performed in the world at different centers. The start of lung transplantation in Turkey has been delayed for various reasons. From 1998 on, there were several attempts but the first successful lung transplant was performed at Sureyyapasa Hospital in 2009. Today there are four lung transplant centers in Turkey
  • No Thumbnail Available
    Item
    Ex-vivo Lung Perfusion and Its Role in Experimental Studies
    (WOLTERS KLUWER MEDKNOW PUBLICATIONS, 2017-01-01) Cosgun, Tugba; Dabak, Gul; Senbaklavaci, Omer
    Lung transplantation is an accepted treatment modality for end-stage lung diseases. However, the donor pool is not getting larger in comparison to the number of patients on the waiting list. Of the patients on the waiting list for lung transplant, more than a quarter dies while waiting. Utilization of marginal donors became an issue, and ex-vivo lung perfusion (EVLP) was started to be performed to solve this problem. Besides that, success in lung transplantation has not reached a satisfactory level for various reasons including ischemia reperfusion injury. Treatment options against these reasons that cause low success of lung transplantations are being investigated by many centers. Nowadays, EVLP that was initially developed to re-evaluate marginal donors has become a method for studies in experimental models. In our article, we want to review EVLP models in experimental studies.